Avanti  NanoSciences’ Biopharmaceutical product portfolio is designed to provide solutions to improve drug development life-cycle by improving R&D efficiency, reduce time to market  at a reduce cost. The NanoBindi/GateKeeper ID technology platform provides specific applications for enhancing the product quality, reducing time for development, better biomarker detection and monitoring for clinical trials, and improved tools for manufacturing and clinical process development.

The biopharmaceutical product portfolio promises to become mission critical for Biopharmaceutical companies as it has been designed by a comprehensive understanding of the changing regulatory environment and system that assure compliance with global regulatory agencies.

A.    Monitoring for Biopharmaceutical ingredients and finished products

 1.      Endotoxin Management Portfolio

a.       EndoSense^TM : Endotoxin Detection

b.      EndoStrip^TM: Endotoxin Removal

c.       EndoMonTM: Endotoxin Monitoring

2.      Rapid Microbial and Viral Detection Tests

3.      Microbial limit Tests

4.      PathAlert: Pathogen screens

5.      VirAlert: Viral pathogen screen

 B.     Instrumentation

1.      GateKeeper ID –Basic

2.      GateKeeper ID –Advanced

C.    Clinical Studies: Products for clinical end point monitoring of disease

        biomarkers